Section

AstraZeneca admits rare blood clot risk from covid jabs as it faces class action lawsuit in UK

By Livemint - 7 months ago
Facing a class action lawsuit in the UK, the drug company acknowledged a rare blood clotting risk from covid jabs.

Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.